OPB-111001

· Otsuka Novel Products GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPB-111001, covering 2015-10-20 to 2015-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer [Phase 1, Phase 2]

See pricing